There are 15 resources available
Welcome and Learning Objectives Review
Presenter: R. Corcoran, US and J. Mateo, ES
Session: Welcome and Learning Objectives Review
Resources:
Slides
Webcast
Origin of CTC and Methods for their Isolation and Molecular Analyses
Presenter: C. Alix-Panabieres, FR
Session: Session 1 - Fundamental Principles of Liquid Biopsies
Resources:
Slides
Webcast
Origin of cfDNA and Tumor EVs
Presenter: F. Moulière, NL
Session: Session 1 - Fundamental Principles of Liquid Biopsies
Resources:
Slides
Webcast
Liquid Biopsy in Non-blood Fluids
Presenter: G. Siravegna, US
Session: Session 1 - Fundamental Principles of Liquid Biopsies
Resources:
Slides
Webcast
NGS, Liquid Biopsies and Predictive Biomarkers for Targeted Therapies: Opportunities and Limitations of the Assays
Presenter: C. Z. Abbosh, UK
Session: Session 2 - Bringing Liquid Biopsy into Clinics
Resources:
Slides
Webcast
Studying Drug Resistance and Tumor Evolution in Liquid Biopsies
Presenter: C. Rolfo, US
Session: Session 2 - Bringing Liquid Biopsy into Clinics
Resources:
Slides
Webcast
The ESMO Recommendations for Multigene Sequencing in Clinical Practice
Presenter: F. Mosele, FR
Session: Session 2 - Bringing Liquid Biopsy into Clinics
Resources:
Slides
Webcast
Circulating Tumor Cell Count Kinetics as Surrogate Endpoint of Antitumor Activity
Presenter: J. Mateo, ES
Session: Session 3 - Quantitative Liquid-biopsy Biomarkers as Clinical Trials End Point
Resources:
Slides
Webcast
Liquid Biopsy and Biomarkers for Precise Use of Immunotherapy
Presenter: L. Siu, CA
Session: Session 3 - Quantitative Liquid-biopsy Biomarkers as Clinical Trials End Point
Resources:
Slides
Webcast
Role of cfDNA in Monitoring Response and Relapse: the Example of Liquid Biopsy Minimal Residual Disease as Clinical Trial Endpoint
Presenter: V. Morris, US
Session: Session 3 - Quantitative Liquid-biopsy Biomarkers as Clinical Trials End Point
Resources:
Slides
Webcast